Brad W. Desilva

Brad W. Desilva

Auto-generated profile, based on publicly available information

Brad W. Desilva

Department of Otolaryngology‐Head and Neck Surgery The Ohio State University Medical Center Columbus Ohio USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AMAnna M. Marcinow
Anna M. Marcinow
JTJennifer Thompson
Jennifer Thompson
TCTendy Chiang
Tendy Chiang
LFL. Arick Forrest
L. Arick Forrest
BDBrad W. Desilva
Brad W. Desilva

25 August 2015 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
AMAnna M. Marcinow
Anna M. Marcinow
JTJennifer Thompson
Jennifer Thompson
LFL. Arick Forrest
L. Arick Forrest
BDBrad W. Desilva
Brad W. Desilva

31 October 2019 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
RIR Ivancic
R Ivancic
HIH Iqbal
H Iqbal
BDB Desilva
B Desilva
QPQ Pan
Q Pan
LML Matrka
L Matrka

13 December 2018 in The Laryngoscope
Verified
Journal Article
Closed access
BDBrad Desilva
Brad Desilva
DCDrew Crenshaw
Drew Crenshaw
LMLaura Matrka
Laura Matrka
LFL. Arick Forrest
L. Arick Forrest

23 January 2023 in The Laryngoscope
Verified
Journal Article
Open access
NTNicholas Talbot
Nicholas Talbot
MHMargaret Heller
Margaret Heller
SNSarah Nyirjesy
Sarah Nyirjesy
BKBrandon Kim
Brandon Kim
BDBrad DeSilva
Brad DeSilva
LMLaura Matrka
Laura Matrka
Objective: Neurogenic cough related to hypersensitivity of the internal branch of the superior laryngeal nerve (SLN) is often treated with neuromodulating medications, which can cause considerable side effects. An alternative therapy is steroid and local anesthetic injection of the SLN (“SLN block”), initially proposed to benefit those with lateralizing symptoms (tenderness over the thyrohyoid membrane or unilateral cough source). Our objectives are to determine if SLN block produces subjective symptomatic improvements and if repeat injections further improve symptoms, and evaluate clinical factors potentially predictive of response.Methods: Retrospective chart review of 54 patients receiving SLN blocks at a tertiary medical academic center from January 2010 to June 2020. Medical history and anticipated predictors of positive response, including stigmata of laryngeal hypersensitivity, were recorded. Outcomes included symptomatic response, number of injections required, and side effects. Response was defined subjectively by asking patients whether the injection was beneficial and objectively by using CSI scores.Results: Fifty‐four patients met the inclusion criteria. Thirty‐eight patients (70.4%) endorsed improvement. No variables were identified as positive predictors of response. Thirty‐two of the 38 (84.2%) endorsed improvement after one injection. Six of 15 (40%) patients who failed the first injection had positive response to the second. No significant side effects were reported.Conclusion: No localizing symptoms, specific cough features, or aspects of the medical history helped predict response, suggesting that a broader range of patients may be offered the intervention. The majority of patients reported symptomatic improvement and repeat injections may benefit patients with initial nonresponse.Level of Evidence: 4 Laryngoscope, 133:2647–2653, 2023

1 April 2010 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
RHRyan M. Hendricker
Ryan M. Hendricker
BDBrad W. Desilva
Brad W. Desilva
LFL. Arick Forrest
L. Arick Forrest